Chaeum Premium No. 1 Regulatory Status: A Professional Sourcing Guide

Chaeum Premium No. 1 is a hyaluronic acid (HA) dermal filler manufactured by Hugel, a prominent South Korean company. As an aesthetic injectable, it falls under specific regulatory categories designed to ensure product safety and quality. Professionals considering this product for their clinic inventory should focus on its original specifications and verified origin from South Korea. This product is part of a broader category of Hyaluronic acid dermal filler catalog products that require careful regulatory scrutiny.

As a product of South Korean origin, Chaeum Premium No. 1 would typically undergo rigorous evaluation by the Korean Ministry of Food and Drug Safety (KFDA) for its domestic market approval. KFDA approval signifies adherence to national manufacturing and quality standards. For international distribution, particularly within the European Union and the UK, the CE Mark is a critical certification. The CE Mark indicates compliance with EU health, safety, and environmental protection standards. [VERIFY: Current KFDA and CE Mark status for Chaeum Premium No. 1]. Obtaining products with verified CE marking ensures they meet the stringent regulatory demands of European markets.

Beyond KFDA and CE Mark, regulatory landscapes vary significantly by region. For markets such as the GCC (Gulf Cooperation Council), LATAM (Latin America), and APAC (Asia-Pacific) countries, specific national health authority registrations or import permits are often required. The US FDA approval, while highly recognized, is less commonly obtained for South Korean HA fillers unless specifically targeted for the American market. Professionals should always [VERIFY: FDA approval status for Chaeum Premium No. 1]. Additionally, manufacturers like Hugel are expected to hold international quality management certifications such as ISO standards and Good Manufacturing Practice (GMP) certifications. [VERIFY: Hugel's GMP and ISO certification status for Chaeum Premium No. 1 manufacturing].

The global market for aesthetic injectables includes various distribution channels, including parallel imports. While parallel imports can sometimes offer different pricing structures, they introduce complexities regarding traceability, cold chain maintenance, and genuine product verification. Clinics must exercise caution to ensure that any Chaeum Premium No. 1 sourced through parallel channels is authentic and legally imported according to local regulations. Our article on How to Verify Genuine Allergan 50unit offers general principles applicable to verifying product authenticity across brands.

To maintain regulatory compliance and ensure product integrity, clinics should consistently demand comprehensive documentation from their wholesale suppliers. This includes Certificates of Analysis for specific product batches, Certificates of Authenticity from the manufacturer or authorized distributor, and proof of cold chain integrity during transit. Such documentation confirms the product’s origin, quality, and legal pathway to your clinic. For further guidance on sourcing, professionals might find our Wholesale Elravie Premier UD: A Professional Sourcing Guide useful.

When sourcing Chaeum Premium No. 1, understanding the wholesale pricing structure and volume tiers is important for inventory management. Illustratively, pricing for Chaeum Premium No. 1 may start at approximately $76.8 per unit, with potential discounts increasing with volume: 4% off for 11 units, 5% for 21 units, 6% for 31 units, and 8% for orders of 51 units or more. These tiers allow clinics to optimize their procurement based on their operational needs. Always confirm current pricing and terms with your supplier. Other products like Bienox 100 Units: Understanding Regulatory and Market Access also have specific market access considerations that impact sourcing.